Stories
Slash Boxes
Comments

SoylentNews is people

posted by Fnord666 on Wednesday June 09, @06:41PM   Printer-friendly
from the did.you.take.the.pill.or.not? dept.

The FDA has approved a new drug for Alzheimer's disease, while not a cure it is supposed to slow the decline. Even though data is not entirely positive or straight forward in its interpretation or that it will actually even work as thought.

But if you have it then you are probably desperate enough to try almost anything that claims to work, until you get to the price tag of $56,000 per year. That will probably make it out of reach for most people, it's doubtful if any insurance will cover something like this. Perhaps you can just forget to pay the bill, they might understand due to your condition.

Biogen CEO Michel Vounatsos [...][said] he thought the drug's price was "fair" but also vowed that the company would not hike its price for four years.

https://www.cnbc.com/2021/06/07/fda-approves-biogens-alzheimers-drug-the-first-new-therapy-for-the-disease-in-nearly-two-decades.html

Previously:
In Surprise Turnaround, Biogen to Submit Previously Failed Alzheimer Drug for Approval
Disputed Alzheimer's Study Links Decrease in Amyloid Levels to Reduction in Cognitive Decline
Positive Result in Mice as Alzheimer's Drug Trials Fail and Regulatory Barriers Are Rolled Back


Original Submission

 
This discussion has been archived. No new comments can be posted.
Display Options Threshold/Breakthrough Mark All as Read Mark All as Unread
The Fine Print: The following comments are owned by whoever posted them. We are not responsible for them in any way.
  • (Score: 3, Informative) by Runaway1956 on Wednesday June 09, @09:59PM (4 children)

    by Runaway1956 (2926) Subscriber Badge on Wednesday June 09, @09:59PM (#1143724) Homepage Journal

    A couple quick searches gave me these:

    https://arstechnica.com/science/2019/01/healthcare-industry-spends-30b-on-marketing-most-of-it-goes-to-doctors/ [arstechnica.com]

    https://www.prescouter.com/2019/06/pharmaceutical-rd-global-spending-trends-in-2019/ [prescouter.com]

    So, 20 billion for advertising, vs 165 billion for R&D. No indication of lobbying and campaign donation costs.

    --
    Make an actual interesting, germane, and relevant point and you may get away with Flamebait - 'Zumi
    Starting Score:    1  point
    Moderation   +1  
       Informative=1, Total=1
    Extra 'Informative' Modifier   0  
    Karma-Bonus Modifier   +1  

    Total Score:   3  
  • (Score: -1, Flamebait) by Anonymous Coward on Wednesday June 09, @10:12PM

    by Anonymous Coward on Wednesday June 09, @10:12PM (#1143726)

    Oh Noes! Moar Runaway Education? Lord save us!

  • (Score: 2) by Beryllium Sphere (r) on Thursday June 10, @12:11AM

    by Beryllium Sphere (r) (5062) on Thursday June 10, @12:11AM (#1143747)

    Thank you.

  • (Score: 2) by PiMuNu on Thursday June 10, @11:33AM

    by PiMuNu (3823) on Thursday June 10, @11:33AM (#1143848)

    Interesting post

  • (Score: 0) by Anonymous Coward on Friday June 11, @09:41PM

    by Anonymous Coward on Friday June 11, @09:41PM (#1144395)

    A couple of problems here. You are comparing only the amount of money spent only on wooing doctors in the US while leaving out all other marketing activities worldwide to total worldwide R&D both public and private.

    But where the money has really gone for huge pharmacology corporations is to stock buybacks. There are a number of articles on that and a recent clip of CEOs getting grilled over where their money goes by a congresswoman a few days ago.